T-TUBES® chosen for Europe’s largest BioPharma facility
Zotefoams plc, the world’s leading manufacturer of closed-cell cross-linked polyolefin foams, has been awarded a contract to supply their T-TUBES® high performance clean room insulation system for Pfizer at its Grange Castle facility in Dublin. Initial deliveries of T-TUBES® were supplied in July 2013, in conjunction with ESI Technologies Ltd, Zotefoams exclusive distributor in Ireland.
The choice of the inherently pure and chemically resistant T-TUBES® product for use in purification, cell culture and harvest and recovery suites, for heat and energy conservation, personal protection and the elimination of condensation and risk of bacteria growth, confirms T-TUBES® as the clean room insulation of choice at Pfizer’s major European Bio-pharmaceutical plant. The simple construction and accelerated and reduced installation time will assist in the completion and commissioning of the expanded site. Specifically, the Grange Castle site will be expanded to deal with the manufacture of an active pharmaceutical ingredient API) for Pfizer’s biologic drug programme.
T-TUBES’® proven track record in significantly reducing installation time and costs, reducing maintenance and operating costs, and eliminating the risk of bacteria growth due to its unique KYNAR® PVDF closed cell structure, was a major factor in Pfizer’s decision to use it throughout their expanded clean room facilities at their US$2.25bn plant. The Grange Castle development is one of the largest integrated biopharmaceutical plants in the world and is the only facility in Europe to manufacture biopharmaceuticals, pharmaceuticals and vaccines within the same facility.BACK TO LIST